Filing Details

Accession Number:
0001209191-16-134691
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-08-01 17:37:21
Reporting Period:
2016-07-28
Filing Date:
2016-08-01
Accepted Time:
2016-08-01 17:37:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1524472 Xylem Inc. XYL () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1226924 R Steven Loranger 1 International Drive
C/O Xylem Inc.
Rye Brook NY 10573
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-07-28 32,246 $30.03 38,334 No 4 M Direct
Common Stock Disposition 2016-07-28 32,246 $48.01 6,088 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2016-07-28 32,246 $0.00 32,246 $30.03
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
100,019 2018-10-31 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 80,367 Indirect By Steven R. Loranger Revocable Trust
Common Stock 50,551 Indirect By Betsy Palmer Loranger Revocable Trust
Footnotes
  1. The exercise and sale was made under a 10b5-1 plan adopted by the reporting person on June 1, 2016.
  2. This price represents the approximate weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $48.00 to $48.05 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.
  3. 6,500 Shares previously reported as directly held, were transferred to the Steven R. Loranger Revocable Trust in transactions exempt from reporting under 16a-13.
  4. These options are fully vested and exercisable.